Target intelligence / Profile preview

RNA, U6 small nuclear 538, pseudogene (RNU6-538P)

Target
RNU6-538P
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

**RNU6-538P** is a member of the U6 small nuclear RNA (snRNA) pseudogene family, which means it is a nonfunctional copy of the gene encoding U6 snRNA[1][5][7]. U6 snRNA itself is an essential component of the spliceosome, a complex responsible for pre-mRNA splicing in eukaryotes[5]. The RNU6-538P gene arises via duplication or retrotransposition and has lost the ability to encode a functional RNA or protein[1][6][7]. Although pseudogenes are sometimes transcribed and can have regulatory effects (such as acting as miRNA decoys or influencing the expression of related genes), there is no direct evidence that RNU6-538P has a defined physiological or pathological role[2][6]. RNU6-538P is not a direct therapeutic target. It belongs to the broader category of pseudogenes, which can occasionally have regulatory or disease-related roles, but RNU6-538P specifically lacks such established functions. The name and classification are accurate; it is representative of non-coding, non-protein-coding genomic elements derived from small nuclear RNAs[1][7].

Other names
RNU6-538P
02

Biological functions

Other (May participate in regulatory non-coding RNA functions, such as acting as a decoy for regulatory RNAs, but is generally considered non-functional)
03

Disease associations

Other (While some pseudogenes play roles in cancer regulation via RNA-mediated mechanisms, no specific disease association is known for RNU6-538P itself)

Beyond the preview

Go deeper on RNA, U6 small nuclear 538, pseudogene (RNU6-538P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 538, pseudogene (RNU6-538P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call